Venture Catalysts Exits Pee Safe with 9.6x Return After OrbiMed-Led $32 Million Round

Early-stage investment fund Venture Catalysts has fully exited women's hygiene and wellness brand Pee Safe, achieving a 9.6x return following a $32 million funding round led by healthcare-focused private equity firm OrbiMed in January 2026. Other early investors, including We Founder Circle, Alkemi Growth Capital, and Alpha Capital, also exited, while Zerodha-backed Rainmatter and Natco Pharma remain investors. Founded in 2017 by Vikas Bagaria, Pee Safe has expanded from public toilet hygiene solutions to a broader personal care portfolio and aims to scale further, potentially via an IPO.